India has an official tally of 17.31 million infections and 195,123 deaths, health ministry data showed, although health experts say the figures probably run higher.

Gilead to help India boost Remdesivir production

Gilead Sciences Inc said on Friday an analysis showed its antiviral remdesivir helped reduce the risk of death in severely ill COVID-19 patients, but cautioned that rigorous clinical trials were needed to confirm the benefit.

Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed

The coronavirus pandemic will not end anytime soon. People are learning to live with the pandemic began six months ago. Governments are still hunting for cures. For now, there is no magic bullet.

Coronavirus crisis: United States buys 90 per cent of Remdesivir stock

The United States has bought almost the entire worldwide stock of the anti-viral drug Remdesivir, which is being considered as a potential cure for coronavirus. As per an announcement made by the US Department of Health and Human Services (HSS) over 500,000 doses of the drug has been bought by the country from its sole manufacturer Gilead Sciences.

US purchases almost entire global stock of potential COVID-19 cure Remdesivir

Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some other developed countries, potentially reflecting looming competition from a cheap steroid.

Gilead gives price tag to first coronavirus drug Remdesivir at $2,340

AstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc about a potential merger. Any deal would bring together two of the companies leading the drug industry's efforts to fight the coronavirus pandemic, according to Bloomberg News.

AstraZeneca and Gilead may head for a merger, says report

Gilead is a company that makes Remdesivir, another drug, that experts say holds promise against coronavirus. In the US, Remdesivir is undergoing clinical trials.

Gilead starts clinical trials of Remdesivir with US lawmakers curious about selling price

American pharmaceutical company Gilead Sciences reported today that its experimental coronavirus therapy remdesivir helped improve symptoms in COVID-19 patients when it was administered early than those who were treated late.

Remdesivir, tested against coronavirus showed positive results: US company Gilead Sciences

A US appeals court on Wednesday dealt a major blow to Merck & Co Inc as it upheld a ruling that threw out a $2.54 billion (£1.97 billion) jury verdict the drugmaker had won against Gilead Sciences Inc.

Merck loses bid to revive $2.54 billion patent verdict against Gilead

gilead

Gilead, News on Gilead, stories on Gilead, articles on Gilead, Gilead stories at Wion, Gilead news, Gilead latest news